Patents by Inventor Elizabeth Mead

Elizabeth Mead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12065511
    Abstract: The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. For example, the peptides may be administered to subjects in need of a mitochondrial-targeted antioxidant.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: August 20, 2024
    Assignee: STEALTH BIOTHERAPEUTICS INC.
    Inventors: D. Travis Wilson, Marc W. Andersen, Elizabeth Mead
  • Publication number: 20210040149
    Abstract: The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. For example, the peptides may be administered to subjects in need of a mitochondrial-targeted antioxidant.
    Type: Application
    Filed: March 13, 2020
    Publication date: February 11, 2021
    Applicant: Stealth BioTherapeutics Corp
    Inventors: D. Travis Wilson, Marc W. Andersen, Elizabeth Mead
  • Publication number: 20180362579
    Abstract: The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. For example, the peptides may be administered to subjects in need of a mitochondrial-targeted antioxidant.
    Type: Application
    Filed: January 9, 2018
    Publication date: December 20, 2018
    Inventors: D. Travis WILSON, Marc W. ANDERSEN, Elizabeth MEAD
  • Publication number: 20140294796
    Abstract: The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. For example, the peptides may be administered to subjects in need of a mitochondrial-targeted antioxidant.
    Type: Application
    Filed: December 5, 2012
    Publication date: October 2, 2014
    Inventors: D. Travis Wilson, Marc W. Andersen, Elizabeth Mead